Why did B8F.DE stock move so sharply intraday today?

The sharp intraday move likely reflects thin order books, concentrated buying and low float rather than confirmed corporate news. Volume of **45,797** versus average **605** shares suggests a trading anomaly or squeeze; check filings and market notices before trading.

What is Meyka AI’s price target for B8F.DE stock?

Meyka AI's forecast model projects a 12-month base case target of **€9.50**, which implies roughly **39.65%** upside versus **€6.804**. Forecasts are model outputs and not guarantees; monitor updates and company disclosures.

Is Biofrontera AG a buy after today’s spike?

Given negative EPS **-€0.21**, small market cap **€20.67M**, and extreme intraday volatility, a cautious stance is prudent. Consider waiting for sustained volume, clearer fundamentals, or news-driven catalysts before taking a position.

DE Stocks

B8F.DE Biofrontera AG (XETRA) surges 2,000% intraday on 17 Feb 2026: volume spike tests outlook

ByHuzaifa Zahoor February 17, 2026

Intraday trading in B8F.DE stock opened with an extreme volume spike and a 2,000.00% move that lifted the price to €6.80 on XETRA on 17 Feb 2026. The swing followed an opening trade at €0.37 and a previous close of €0.32, while volume hit 45,797 versus an average of 605 shares. This makes B8F.DE one of today’s highest-volume movers in the German Healthcare group and raises questions about liquidity, catalysts, and short-term upside. We break down the price action, fundamentals, technicals, our proprietary grade and a model-based forecast to help traders and investors assess the situation.